Cargando…

P1712: CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS

Detalles Bibliográficos
Autores principales:	Güven, Z., Keklik, M., Ünal, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429638/ http://dx.doi.org/10.1097/01.HS9.0000849704.44599.27

Ejemplares similares

CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS
por: GÜVEN, Zeynep Tuğba, et al.
Publicado: (2022)

Coronavirus Anxiety Level and COVID-19 Vaccine Attitude Among Patients With Hematological Malignancies
por: Güven, Zeynep Tuğba, et al.
Publicado: (2023)

P1745: ADHERENCE TO TREATMENT OF HEMATOLOGICAL MALIGNANCIES PATIENTS WITH ANXIETY AND DEPRESSION
por: Vybornykh, D. E., et al.
Publicado: (2022)

Thomas Dimsdale [1712-1800]
Publicado: (1932)

1712. Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in Children in the post-2009 Pandemic Era
por: Kamidani, Satoshi, et al.
Publicado: (2020)

P1557: A STUDY ON THE IMMUNOGENICITY OF COVID-19 VACCINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCY
por: Mesina, Flordeluna, et al.
Publicado: (2023)

Haciendas y ranchos de Tlaxcala en 1712 /
Publicado: (1969)

P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Tamariz-Amador, L.-E., et al.
Publicado: (2022)

P1574: ANTINEOPLASTIC THERAPY FOR HEMATOLOGIC MALIGNANCIES DURING COVID-19
por: Chudnova, T., et al.
Publicado: (2022)

P1700: EARLY APPEARANCE OF CARDIOTOXICITY, IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES (HM)
por: Antoniadi, K., et al.
Publicado: (2022)

Evaluation of risk factors for mortality in hematological malignancy patients admitted to intensive care unit
por: Ileri, I, et al.
Publicado: (2015)

P1614: MOLECULAR EPIDEMIOLOGY OF INFLUENZA VIRUS IN PATIENTS WITH HEMATOLOGIC DISORDERS
por: Ünal, S., et al.
Publicado: (2022)

P1574: EFFICACY AND SAFETY OF TIXAGEVIMAB AND CILGAVIMAB (EVUSHELD) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Aleshina (Gavrilina), Olga, et al.
Publicado: (2023)

PB1712: LYOPHILIZATION BASED ISOLATION OF EXOSOMES FOR DELIVERY OF DRUGS AND PROTEIN
por: Rehman, Fawad Ur, et al.
Publicado: (2023)

P1551: INCIDENCE AND PREDICTORS FACTORS FOR 30-DAY UNPLANNED HOSPITAL READMISSION AMONG HEMATOLOGIC MALIGNANT DISEASE PATIENTS
por: LI, Xiao, et al.
Publicado: (2023)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

Draft Whole-Genome Sequence of “Candidatus Liberibacter asiaticus” Strain TX1712 from Citrus in Texas
por: Cai, W., et al.
Publicado: (2018)

COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies
por: Martinez Lopez, Joaquin, et al.
Publicado: (2022)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

P1569: HERPES ZOSTER VACCINATION IN HEMATOLOGY. A SINGLE CENTER EXPERIENCE.
por: Rodriguez, Natalia De Las Heras, et al.
Publicado: (2023)

P1588: A SINGLE CENTER COMPARATIVE CLINICAL ANALYSIS OF THE SARS-COV-2 INFECTION BEFORE AND AFTER VACCINATION IN PATIENTS DIAGNOSED WITH HEMATOLOGIC MALIGNANCIES
por: Jiménez, M., et al.
Publicado: (2022)

P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY
por: Vitkon, Roy, et al.
Publicado: (2023)

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY
por: Lucijanic, M., et al.
Publicado: (2022)

P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.
por: Callegari, Chiara, et al.
Publicado: (2023)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

P1590: OUTCOME OF HYPERBARIC OXYGEN THERAPY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES –A TERTIARY CANCER CENTER EXPERIENCE
por: Kim, K., et al.
Publicado: (2022)

P1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY
por: Kuruvilla, J., et al.
Publicado: (2022)

P1721: PROGNOSTIC FACTORS IN PATIENTS IN THE TERMINAL PHASE OF HEMATOLOGICAL MALIGNANCIES WHO RECEIVED HOME MEDICAL CARE
por: Miyashita, N., et al.
Publicado: (2022)

P1723: A FEASIBILITY STUDY OF PEER SUPPORT IN FAMILY CAREGIVERS OF PATIENTS NEWLY DIAGNOSED WITH HEMATOLOGIC MALIGNANCY
por: Nielsen, I. H., et al.
Publicado: (2022)

P1339: IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL
por: Woo, Janghee, et al.
Publicado: (2023)

P1524: EFFECTS OF CORONAVIRUS DISEASE 2019 (COVID-19) VACCINATION ON HEMOGLOBIN LEVELS IN THALASSEMIA PATIENTS
por: Vanavanitkun, R., et al.
Publicado: (2022)

P1715: KNOWLEDGE, ATTITUDES, ANXIETY, AND COPING STRATEGIES OF PEDIATRIC PATIENTS, PARENTS, AND HEALTH CARE PROVIDERS AFTER A LEUKEMIA DIAGNOSIS
por: Yaşar, Y., et al.
Publicado: (2022)

Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?
por: KORKMAZ, Serdal, et al.
Publicado: (2019)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

PIV-21 Respiratory viral infections in adult patients with hematologic malignancies
por: Bayram, A., et al.
Publicado: (2009)

Attitudes towards vaccination and HPV vaccine uptake among Croatian university students
por: Miskulin, I, et al.
Publicado: (2023)

Andrea Tron (1712-1785) e la crisi dell'aristocrazia senatoria a Venezia.
por: Tabacco, Giovanni
Publicado: (1957)

1712. Candida auris: A Case Series at a Large Tertiary Care Medical System
por: Yeturu, Preethi, et al.
Publicado: (2019)

Thomas Dimsdale, M.D., F.R.S. (1712-1800): And the Inoculation of Catherine the Great of Russia
por: Bishop, W. J.
Publicado: (1932)

Biofilm formation and antagonistic activity of Lacticaseibacillus rhamnosus (PTCC1712) and Lactiplantibacillus plantarum (PTCC1745)
por: Rezaei, Zeinab, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lgddf80a0b7esu53bill5uho0e